Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-95.60	183.50	-4168.14
Graham Fair Price	93.69	19.34	9.99
PEG	-73.46	-0.16	0.61
Price/Book	10.34	14.82	13.43
Price/Cash Flow	174.27	238.02	86.78
Prices/Earnings	-49.94	62.22	-124.29
Price/Sales	42.24	13.48	9.48
Price/FCF	174.27	238.02	86.78
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.29	0.28	0.26
Operating Margin	303.85	0.05	-0.01
ROA	165.86	0.02	< 0.005
ROE	-0.03	0.06	120.41
ROIC	< 0.005	0.03	343.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	-0.02	95.03
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.24	5.11	127.64
EPS QOQ	-2.03	3.83	88.65
FCF QOQ	0.87	-0.47	-45.74
Revenue QOQ	0.04	0.02	-53.20
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	22.11	19.75	-10.66
Inventory Turnover	2629747582.00	0.00	inf
Debt/Capitalization	0.33	0.55	68.84
Quick Ratio	1.24	1.38	10.76
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.81	16.71	30.46
Cash	21.39	23.59	10.26
Capex	< 0.005	-0.03	-369.84
Free Cash Flow	1.98	1.04	-47.51
Revenue	18.14	18.36	1.20
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.29	1.42	10.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	182.07	-6.54	-96.41
Naive Interpretation	Member

06 - Financial Health · Weak

Rating